Swiss Life Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Swiss Life Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,034	Closed	-$213K	–	1729
2026 Q1	$213K	Buy	+4,034	New	+$166K	﹤0.01%	1347

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Swiss Life Asset Management's TERN Position: Q2 2026 in Review

Swiss Life Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 4,034 shares — an estimated $213K sold.

Swiss Life Asset Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $213K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Swiss Life Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Swiss Life Asset Management sold 4,034 Terns Pharmaceuticals shares in Q2 2026, an estimated $213K.
Swiss Life Asset Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Swiss Life Asset Management's Terns Pharmaceuticals position peaked at $213K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.